Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
Vaccines (Basel). 2023 Jan 28;11(2):286. doi: 10.3390/vaccines11020286.
Vaccines (Basel). 2023.
PMID: 36851164
Free PMC article.
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
Esteban I, Pastor-Quiñones C, Usero L, Aurrecoechea E, Franceschini L, Esprit A, Gelpí JL, Martínez-Jiménez F, López-Bigas N, Breckpot K, Thielemans K, Leal L, Gómez CE, Sisteré-Oró M, Meyerhans A, Esteban M, Alonso MJ, García F, Plana M; COVARNA Consortium.
Esteban I, et al.
Vaccines (Basel). 2023 Dec 22;12(1):15. doi: 10.3390/vaccines12010015.
Vaccines (Basel). 2023.
PMID: 38250827
Free PMC article.
Item in Clipboard
Cite
Cite